ICARES Medicus, Inc.

TPEX:6612 Stock Report

Market Cap: NT$5.2b

ICARES Medicus Past Earnings Performance

Past criteria checks 1/6

ICARES Medicus has been growing earnings at an average annual rate of 10.2%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 13.2% per year. ICARES Medicus's return on equity is 1.2%, and it has net margins of 8.9%.

Key information

10.2%

Earnings growth rate

8.7%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate13.2%
Return on equity1.2%
Net Margin8.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Returns On Capital Signal Tricky Times Ahead For ICARES Medicus (GTSM:6612)

Mar 22
Returns On Capital Signal Tricky Times Ahead For ICARES Medicus (GTSM:6612)

ICARES Medicus, Inc. (GTSM:6612) On An Uptrend: Could Fundamentals Be Driving The Stock?

Feb 24
ICARES Medicus, Inc. (GTSM:6612) On An Uptrend: Could Fundamentals Be Driving The Stock?

Would Shareholders Who Purchased ICARES Medicus' (GTSM:6612) Stock Year Be Happy With The Share price Today?

Jan 12
Would Shareholders Who Purchased ICARES Medicus' (GTSM:6612) Stock Year Be Happy With The Share price Today?

Here's What To Make Of ICARES Medicus' (GTSM:6612) Returns On Capital

Dec 15
Here's What To Make Of ICARES Medicus' (GTSM:6612) Returns On Capital

ICARES Medicus, Inc.'s (GTSM:6612) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Nov 24
ICARES Medicus, Inc.'s (GTSM:6612) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Revenue & Expenses Breakdown

How ICARES Medicus makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TPEX:6612 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2474266265178
30 Jun 2464570235176
31 Mar 2461895209174
31 Dec 2360598196177
30 Sep 23604127183178
30 Jun 23575138174170
31 Mar 23541125166150
31 Dec 22512129160133
30 Sep 22487132146122
30 Jun 22458101143107
31 Mar 2242982136106
31 Dec 2139459130105
30 Sep 2135332122100
30 Jun 2134636115101
31 Mar 2134235116101
31 Dec 203635211598
30 Sep 2040571125102
30 Jun 204197413398
31 Mar 2045497135101
31 Dec 194198113591
30 Sep 193757012476
30 Jun 193466211465
31 Mar 193226410948
31 Dec 183297010741
30 Sep 183135811038
30 Jun 183136210939
31 Mar 182864110641
31 Dec 172663110140
30 Sep 17277389947
30 Jun 172642210144
31 Mar 17247179639
31 Dec 16246199538
31 Dec 1521797938
31 Dec 14179-396854

Quality Earnings: 6612 has a high level of non-cash earnings.

Growing Profit Margin: 6612's current net profit margins (8.9%) are lower than last year (21.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 6612's earnings have grown by 10.2% per year over the past 5 years.

Accelerating Growth: 6612's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 6612 had negative earnings growth (-48.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (1.7%).

Return on Equity

High ROE: 6612's Return on Equity (1.2%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:03
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ICARES Medicus, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhennan LeeJih Sun Securities Investment Consulting Co., Ltd.
null nullKGI Securities Co. Ltd.
Hsiu Chi LinMasterlink Securities Corp.